skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307 (Code C78862)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307

Definition: A cancer vaccine, containing human-specific large multivalent immunogen (LMI) isolated from plasma membrane fractions of the melanoma cell lines MSM-M1 and MSM-M2, with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen melanoma vaccine LP2307 may stimulate a CD8+ cytotoxic T lymphocyte (CTL) response against melanoma tumor cells that express melanoma-specific LMI.

Display Name: Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307

Label: Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307

NCI Thesaurus Code: C78862 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL387595  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
Allogeneic LMI Melanoma Vaccine LP2307
LP2307

External Source Codes: 
PDQ Closed Trial Search ID 602166
PDQ Open Trial Search ID 602166 (check for NCI PDQ open clinical trial info)
NCI META CUI CL387595

Other Properties:
     Name Value (qualifiers indented underneath)
code C78862
Contributing_Source CTRP
Legacy_Concept_Name Allogeneic_Large_Multivalent_Immunogen_Melanoma_Vaccine_LP2307
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C78862

Mainbox Bottom